ACLY and lung carcinoma: ATP citrate lyase (ACLY), which is a key enzyme of de novo fatty acid synthesis, was found to be upregulated in numerous types of cancer, and it is inhibited by miR-22 in osteosarcoma and lung cancer cells [95].